GlaxoSmithKline could cut up to 60 workers at U.K. site as it ends production of antibiotic chemical
GlaxoSmithKline has reportedly worked in recent months to shake up its antibiotics business after at least one failed attempt to divest products. Now, dozens of GSK employees could wind up on the cutting room floor as the drugmaker shifts away from producing a key antibiotic component. The British drugmaker will look to trim positions at… Read More »